Drug Shortage Report for TEVA-CYCLOSPORINE
| Report ID | 156410 |
| Drug Identification Number | 02462486 |
| Brand name | TEVA-CYCLOSPORINE |
| Common or Proper name | CYCLOSPORINE 0.05% OPH SOLN |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CYCLOSPORINE |
| Strength(s) | 0.05% |
| Dosage form(s) | EMULSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 0.4ml |
| ATC code | S01XA |
| ATC description | OTHER OPHTHALMOLOGICALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-03-09 |
| Estimated end date | 2022-08-31 |
| Actual end date | 2022-05-18 |
| Shortage status | Resolved |
| Updated date | 2022-05-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2022-05-19 | French | Compare |
| v9 | 2022-05-19 | English | Compare |
| v8 | 2022-05-12 | French | Compare |
| v7 | 2022-05-12 | English | Compare |
| v6 | 2022-04-21 | French | Compare |
| v5 | 2022-04-21 | English | Compare |
| v4 | 2022-03-17 | French | Compare |
| v3 | 2022-03-17 | English | Compare |
| v2 | 2022-03-10 | French | Compare |
| v1 | 2022-03-10 | English | Compare |
Showing 1 to 10 of 10